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Activation of Nrf2 in keratinocytes causes
chloracne (MADISH)-like skin disease in mice
Matthias Schäfer1,*, Ann-Helen Willrodt1, Svitlana Kurinna1, Andrea S Link2, Hany Farwanah3,
Alexandra Geusau4, Florian Gruber4, Olivier Sorg5, Aaron J Huebner6, Dennis R Roop6, Konrad
Sandhoff3, Jean-Hilaire Saurat5, Erwin Tschachler4, Marlon R Schneider7, Lutz Langbein8, Wilhelm
Bloch9, Hans-Dietmar Beer10 & Sabine Werner1
Abstract
The transcription factor Nrf2 is a key regulator of the cellular stress
response, and pharmacological Nrf2 activation is a promising strat-
egy for skin protection and cancer prevention. We show here that
prolonged Nrf2 activation in keratinocytes causes sebaceous gland
enlargement and seborrhea in mice due to upregulation of the
growth factor epigen, which we identified as a novel Nrf2 target.
This was accompanied by thickening and hyperkeratosis of hair fol-
licle infundibula. These abnormalities caused dilatation of infun-
dibula, hair loss, and cyst development upon aging. Upregulation
of epigen, secretory leukocyte peptidase inhibitor (Slpi), and small
proline-rich protein 2d (Sprr2d) in hair follicles was identified as
the likely cause of infundibular acanthosis, hyperkeratosis, and cyst
formation. These alterations were highly reminiscent to the pheno-
type of chloracne/metabolizing acquired dioxin-induced skin ham-
artomas (MADISH) patients. Indeed, SLPI, SPRR2, and epigen were
strongly expressed in cysts of MADISH patients and upregulated by
dioxin in human keratinocytes in an NRF2-dependent manner.
These results identify novel Nrf2 activities in the pilosebaceous
unit and point to a role of NRF2 in MADISH pathogenesis.
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Introduction
The skin functions as a barrier, which protects our body from harmful
environmental insults, including microorganisms, UV light, and toxic
chemicals. Many of them lead to the formation of reactive oxygen
species (ROS), which at high concentrations damage cellular macro-
molecules. ROS-induced damage is therefore involved in skin tumor
formation, aging, and in the pathogenesis of inflammatory skin
diseases, such as psoriasis, atopic dermatitis, and contact dermatitis.
The skin has evolved effective mechanisms for the protection
from ROS damage, including ROS detoxification and DNA repair. A
master regulator of the cellular antioxidant defense is nuclear factor
erythroid derived 2, like 2 (Nrf2). This transcription factor induces
expression of various genes involved in the cellular redox balance,
including the genes encoding glutamate cysteine ligase modifier
(Gclm) and catalytic (Gclc) subunits, phase II detoxifying enzymes,
such as NAD(P)H dehydrogenase, quinone 1 (Nqo1), and transport-
ers, including multidrug resistance proteins (Mrps).
Nrf2 expression and activity form a basal to suprabasal gradient
in the murine epidermis, which contributes to an intra-epidermal
cytoprotection gradient. This results in strong protection of the
uppermost epidermal layers from ROS-induced damage (Scha¨fer
et al, 2010; Piao et al, 2012). Nrf2 gets further activated by
electrophilic compounds, which directly bind and inactivate the
Nrf2 inhibitor protein Keap1 (Tong et al, 2006).
Due to its central role in ROS detoxification, Nrf2 is an attractive tar-
get for pharmacological protection of the skin. A variety of Nrf2 activa-
tors, including sulforaphane, tert-butyl-hydroquinone (tBHQ), and
resveratrol, have been discovered, which are antioxidant supplements
of cosmetic products. Some of these compounds protected cultured
keratinocytes from damage induced by UV irradiation or treatment with
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toxic chemicals (Gao et al, 2001; Liu et al, 2011; Lieder et al, 2012). In
vivo, short-term topical sulforaphane treatment protected skin from
acute UV toxicity and from chemically and UV-induced carcinogenesis
(Dinkova-Kostova et al, 2006; Gills et al, 2006). Furthermore,
UVB-induced ROS damage and subsequent keratinocyte apoptosis were
reduced in transgenic mice expressing a constitutively active Nrf2
(caNrf2) mutant in keratinocytes (Scha¨fer et al, 2010).
However, there is increasing evidence for harmful consequences
of Nrf2 activation in the skin. A variety of cysteine-reactive skin sen-
sitizers, such as oxazolone or 2,4-dinitrofluorobenzene (DNFB), acti-
vate Nrf2, which contributes to their skin sensitization potential
(Natsch, 2010). Furthermore, long-term Nrf2 activation in murine
skin through deletion of the Nrf2 inhibitor Keap1 caused hyperkera-
tosis (Wakabayashi et al, 2003). Even more worrisome is the corre-
lation of stabilized Nrf2 with increased malignancy and
chemoresistance of tumor cells (Sporn & Liby, 2012). This is
important for the skin, since Nrf2 activating mutations have been
identified in human cutaneous squamous cell carcinomas (Kim et al,
2010). It is therefore essential to analyze the harmful consequences
of Nrf2 activation and to understand the underlying mechanisms.
Genetic and pharmacological Nrf2 activation in murine keratino-
cytes in vivo induced severe acanthosis and hyperkeratosis strongly
resembling ichthyosis in humans (Scha¨fer et al, 2012). This was caused
by Nrf2-induced overexpression of secretory leukocyte peptidase inhib-
itor (Slpi) and of the small proline-rich protein 2d (Sprr2d) in the
epidermis. These two proteins normally contribute to the ROS-protec-
tive and anti-inflammatory activities of Nrf2 (Ishii et al, 2005; Vermeij
et al, 2011). However, elevated expression of Slpi impaired the desqua-
mation of the stratum corneum,most likely due to inhibition of the pro-
teinase kallikrein 7, which degrades corneodesmosomes. The
enhanced levels of the cornified envelope protein Sprr2d caused cor-
neocyte fragility, resulting in a barrier defect and subsequent mild
inflammation and keratinocyte hyperproliferation (Scha¨fer et al, 2012).
Here we used a genetic and a pharmacological strategy to iden-
tify novel effects of Nrf2 on the pilosebaceous unit, and we identi-
fied responsible target genes. Importantly, the abnormalities
observed upon Nrf2 activation in mice strongly resemble the pathol-
ogy seen in patients with chloracne/metabolizing acquired dioxin-
induced skin hamartomas (MADISH; Saurat & Sorg, 2010) at the his-
tological and molecular level and point to a role of activated NRF2
in the pathogenesis of this disorder.
Results
Nrf2 activation in keratinocytes causes sebaceous gland
hypertrophy and sebum congestion
We previously generated transgenic mice expressing a caNrf2
mutant under control of a b-actin promoter and CMV enhancer in
keratinocytes using a strategy that allows expression of the trans-
gene in the presence of Cre recombinase. For expression of caNrf2
in all keratinocytes, mice expressing Cre under the control of the
keratin 5 (K5) promoter were used (Ramirez et al, 2004). The dou-
ble transgenic mice, designated K5cre-CMVcaNrf2 mice, are charac-
terized by acanthosis and severe hyperkeratosis in the epidermis
(Scha¨fer et al, 2012). Interestingly, histological analyses and immu-
nofluorescence staining for perilipin 2 (adipophilin, Adph) showed
that the sebaceous glands (SG) in back and tail skin (Fig 1A,B) and
the meibomian glands of the eyelids (Supplementary Fig 1A) are
strongly enlarged in K5cre-CMVcaNrf2 mice. Consistent with these
findings, their tail skin was oily and sticky, and the eyes were wet
and sometimes partially closed, suggesting sebum/meibum overpro-
duction (seborrhea).
Repeated topical treatment with the Nrf2-activating compounds
sulforaphane or tert-butyl hydroquinone (tBHQ) (Scha¨fer et al,
2012) also caused enlargement of SGs in wild-type mice (Fig 1C),
but not in Nrf2 ko mice (Supplementary Fig 1B), demonstrating that
activation of endogenous Nrf2 has a similar effect as the caNrf2
transgene.
In addition to the SG abnormalities, K5cre-CMVcaNrf2 mice had
dilated hair follicle infundibula (Fig 1D, upper and lower panel). Oil
Red O staining revealed the presence of sebum in the widened infund-
ibula of K5cre-CMVcaNrf2 mice (Fig 1D, upper panel), which were
characterized by strong acanthosis and hyperkeratosis (Fig 1D,
lower panel and 1E). Together, hyperkeratosis of infundibula and
the interfollicular epidermis subsequently form a mechanical bar-
rier, which prevent sebum outflow. The dilatation of the infundibu-
lum was even more severe in hair follicles without a hair, most
likely because the hair prevented a complete occlusion of the hair
follicle by the hyperkeratotic stratum corneum and thus enabled
sebum outflow (Fig 1F). Hyperkeratosis, in combination with
sebum congestion, lead to keratin and sebum accumulation, and
the resulting pressure finally caused dilatation of hair follicle
infundibula (see scheme in Fig 2F).
K5cre-CMVcaNrf2 mice exhibit cyclic hair loss and
malformed hairs
In addition to the SG abnormalities, K5cre-CMVcaNrf2 mice exhib-
ited cyclic hair loss, resulting in patchy baldness during catagen and
telogen (Fig 2A and Supplementary Fig 1C–E). This was not due to
a reduction in the number of hair follicles in the affected areas (Sup-
plementary Fig 1F). Moreover, the follicles underwent all phases of
the hair cycle, although the hair cycle of transgenic mice preceded
the cycle of control mice by approximately 4 days (Supplementary
Fig 2). Anagen hair follicles had a normal length, and follicles
included a hair. Immunostaining of keratins expressed in various
root sheath compartments revealed no obvious defects in differenti-
ation of lower hair follicle keratinocytes (root sheath) and tricho-
cytes (hair fiber) during hair formation (Supplementary Fig 3).
Thus, hair follicles of K5cre-CMVcaNrf2 mice undergo normal differ-
entiation and obviously form a functional hair during anagen,
which, however, is lost prematurely during catagen or telogen.
Interestingly, telogen pelage hairs were only anchored in the lower
part of hair follicles due to dilation of infundibula (Fig 2B), suggest-
ing that the hair loss during catagen and telogen is the consequence
of reduced anchorage of pelage hairs.
The remaining pelage hair as well as the whiskers of K5cre-
CMVcaNrf2 mice appeared shaggy and wavy (Supplementary Fig
1G). Furthermore, the majority of pelage hairs was thinner and
curly (Supplementary Fig 1H) and had spiky cuticle cells (Supple-
mentary Fig 1J), which explains the shaggy appearance of the
remaining fur. These malformations of the remaining hairs are most
likely the consequence of the narrowing of the hair canal due to
infundibular hyperkeratosis and acanthosis.
© 2014 The Authors. EMBO Molecular Medicine Vol 6 | No 4 | 2014
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Nrf2 activation affects hair follicles and sebaceous glands in a
dose-dependent manner
In K5cre-caNrf2 mice, caNrf2 is also under control of a b-actin pro-
moter, but not of a CMV enhancer, resulting in a weaker activation
of Nrf2 target genes compared with K5cre-CMVcaNrf2 mice (Scha¨fer
et al, 2010). K5cre-caNrf2 mice also had curly hairs and they lost
pelage hairs, but this was only observed 5–6 weeks after birth and
was restricted to the tail (Supplementary Fig 4A–C). This locally
restricted phenotype correlates with the stronger expression of Nrf2
(endogenous Nrf2 plus transgene-derived caNrf2) and its target
genes Nqo1, Gclc, Gclm, and sulfiredoxin1 (Srxn1) in the tail com-
pared with the back skin (Supplementary Fig 4D). Histological
analyses and Adph immunofluorescence staining of tail skin sec-
tions identified enlarged SGs, an increased number of sebocytes
(Supplementary Fig 4E–H), sebum-filled infundibula (Supplemen-
tary Fig 4E arrow), and dilatation of infundibula (Supplementary Fig
4F). These abnormalities were similar as in K5cre-CMVcaNrf2 mice,
but less pronounced, demonstrating a strong dependency of the phe-
notype on the level of Nrf2 activation.
Aged K5cre-CMVcaNrf2 mice develop large cutaneous and
meibomian cysts
In one-year-old (1 y) K5cre-CMVcaNrf2 mice, we found a more
severe dilatation and keratinization of infundibula in back (Supple-
mentary Fig 5A) and tail skin (Fig 2C) when compared to young
mice. In addition, keratinized infundibular cysts of different sizes
(Fig 2C) and a few macroscopically visible large cysts were
observed in the tail skin (Fig 2D, Supplementary Table 1). The
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Figure 1. Morphology of sebaceous glands and infundibula in K5cre-CMVcaNrf2 mice.
A Upper panel: H&E staining of longitudinal back skin sections. Scale bar: 100 lm. Middle and lower panel: immunofluorescence staining for Adph on longitudinal back
skin (middle panel) and transverse tail skin sections (lower panel) of P32 tg/wt and tg/tg mice. Note larger SG in tg/tg back and tail. Scale bar: 50 lm.
B Back skin SG area in P10 (N = 7/6, **P = 0.0012) and P32 (N = 5/7, **P = 0.0025) tg/wt and tg/tg mice.
C Morphometrical analysis of SG area of untreated, vehicle (N = 10/6, **P = 0.0017), sulforaphane (N = 6, **P = 0.0022), and tBHQ (N = 6, **P = 0.0022) treated wt mice.
D Oil Red O (upper panel) and H&E staining (lower panel) of longitudinal back skin sections of P32 tg/wt and tg/tg mice. In tg/tg mice, infundibula (INF) are filled with
sebum (indicated by arrow in upper panel), thickened (indicated by bar in lower panel), and hyperkeratotic (indicated by arrows in lower panel). Scale bars: 25 lm.
E Average thickness of infundibula (N = 5, *P = 0.0119) of tg/wt and tg/tg mice.
F H&E staining of longitudinal back skin sections of 8 w tg/wt and tg/tg mice. Note dilatation of infundibula in tg/tg mice. Scale bar: 50 lm.
Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test. AV, average; E, epidermis; D, dermis; HF, hair follicle;
INF, infundibulum; SG, sebaceous gland.
EMBO Molecular Medicine Vol 6 | No 4 | 2014 © 2014 The Authors.
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cutaneous cysts were mainly filled with keratin and to a much lesser
extent with lipids as indicated by H&E and oil red O staining
(Fig 2C,E). In addition, serial sections revealed that only small or no
SGs are associated with the large cysts. In some of the large cysts,
we found a rupture of the epithelial wall, most likely due to keratin
overproduction and consequent enlargement of the cyst lumen
(Supplementary Fig 5B). These cysts are of hair follicle origin, since
the epithelial cells expressed K14 (ORS- and basal infundibulum
cells), keratin K6 (ORS- and active/hyperproliferative infundibulum
cells), but not K10 and loricrin (Lor) (both missing in ORS cells)
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Figure 2. Cyclic hair loss and cutaneous cyst formation in K5cre-CMVcaNrf2 mice.
A Tg/tg mouse at P26, P28, P30, P32, P35, P40, and P45. Note visible hair growth at P26 to P32 (anagen) and hair loss at P35 and P40 (catagen). Arrows point to the same
islet of hairs at P26 and P45.
B H&E staining of longitudinal back skin sections of P40 tg/wt and tg/tg mice. Note widened infundibulum (INF) and reduced anchorage of hair (indicated by dashed line
in upper panel). Scale bar: 50 lm.
C H&E staining of longitudinal tail skin sections of 1-year (1 y)-old mice showing dilatation (indicated by arrow in left panel) and cysts (right panel) in the tail skin of tg/
tg mice. Scale bar: 50 lm.
D Tail skin of 1-y-old tg/wt and tg/tg mice. Note large cysts in tg/tg mice.
E Oil red O staining of a large tail skin cyst. Note ring-shaped weak oil red O staining. Arrow points to sebum in a hair follicle. Scale bar: 100 lm.
F Model of the pilosebaceous phenotype in K5cre-CMVcaNrf2 mice. Left panel: scheme of the pilosebaceous unit of wild-type skin. Arrows indicate sebocyte differentiation
and sebum flow (yellow) in the SG. Middle panel: scheme of the pilosebaceous unit of young K5cre-CMVcaNrf2 mice. SG hyperplasia causes seborrhea. Acanthosis and
hyperkeratosis of infundibula as well as hyperkeratosis of the interfollicular epidermis impair sebum outflow. Together, this results in dilatation of infundibula.
Consequently, the hair anchorage is reduced, resulting in hair loss. Right panel: In aged K5cre-CMVcaNrf2 mice, continuous keratinization leads to formation of
keratinized cutaneous cysts.
© 2014 The Authors. EMBO Molecular Medicine Vol 6 | No 4 | 2014
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(Supplementary Fig 5C). Thus, in aged K5cre-CMVcaNrf2 mice, the
continuous hyperkeratinization of infundibula, which starts already
in young mice, leads to progressive dilatation of infundibula and
ultimately to formation of cutaneous cysts (Fig 2F).
In preputial glands of aged K5cre-CMVcaNrf2 mice, where caNrf2
is also strongly expressed as reflected by the strong expression of its
target genes (Supplementary Fig 5D), we observed hyperkeratosis of
the luminal duct (Supplementary Fig 5E). Ultimately, this resulted
in preputial gland swelling due to sebum congestion (Supplemen-
tary Fig 5F,G).
Activation of Nrf2 induces sebocyte hyperproliferation and
disturbs sebocyte differentiation and lipid metabolism
In the back of P32 K5cre-CMVcaNrf2 mice as well as in the tail of
K5cre-caNrf2 mice, we found a significant increase in the number of
A
D
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Figure 3. Sebocyte proliferation, differentiation, and lipid metabolism in K5cre-CMVcaNrf2 mice.
A BrdU staining on skin sections of tg/wt and tg/tg mice. Arrowheads point to BrdU-positive sebocytes. The dotted line marks the boundary of the SGs. Scale bar:
50 lm.
B Quantification of BrdU-positive sebocytes per circumference of SG in P32 tg/wt and tg/tg mice (N = 4, *P = 0.0286).
C, D qRT-PCR for Adph (N = 4, *P = 0.0286), Pparg (N = 4, *P = 0.0286) and Mc5r (N = 3) (C) and Scd1 (*P = 0.0286), Scd2, Scd3, and Scd4 (*P = 0.0286, N = 4) (D) relative
to Gapdh using RNAs from skin of P32 control (tg/wt) and K5cre-CMVcaNrf2 (tg/tg) mice. Expression in tg/wt mice was arbitrarily set as 1 (dashed line).
E qRT-PCR of Adph, Ppar and Scd1 in P2.5 control and K5cre-CMVcaNrf2 mice (N = 3).
F Separation of cholesterol (Chol), free fatty acids (FA), triacylglycerides (TAG), and cholesterol- and wax esters (CE) by HPTLC in control (tg/wt) and K5cre-CMVcaNrf2
(tg/tg) mice.
G Wet weight ratio of cholesterol, free fatty acids, triacylglycerides, and cholesterol- and wax esters relative to total skin protein. Note the reduction in TAG levels in tg/
tg mice.
H In situ hybridization on back skin sections from 8-w-old tg/wt and tg/tg mice using Epgn sense (upper panel) and antisense probes (lower panel). Note strong staining
in interfollicular epidermis and pilosebaceous unit, particularly on tg/tg section hybridized with the Epgn antisense probe. Scale bar: 50 lm.
I qRT-PCR of Epgn relative to Gapdh using RNAs from skin of P2.5 and P32 tg/wt and tg/tg mice (N = 3). Expression in tg/wt mice was arbitrarily set as 1 (dashed line).
J qRT-PCR of epidermal growth factor (EGF) family members in P32 tg/wt and tg/tg mice (N = 3/4).
Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test.
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proliferating sebocytes in relation to the circumference of the SG as
determined by 5-bromo-2‘-deoxyuridine (BrdU) labeling (Fig 3A,B
and Supplementary Fig 6A,B). This provides a likely explanation for
the severe SG hyperplasia in these mice. Furthermore, expression of
the SG markers Adph and peroxisome proliferator-activated receptor
gamma (Pparg) (Rosenfield et al, 1999) (Fig 3C) was increased,
which correlates with the enlargement of SG in these mice. How-
ever, the late SG differentiation marker melanocortin-5 receptor
(Mc5r) (Chen et al, 1997; van der Kraan et al, 1998) was not upreg-
ulated concomitantly (Fig 3C), indicating a disturbance in late dif-
ferentiation or maturation of sebocytes. Consistent with this
observation, we found a differential expression of stearoyl-CoA
desaturases (Scds; D9 desaturases), which catalyze the conversion
of saturated into mono-unsaturated fatty acids (Guillou et al, 2010).
Scd1 was strongly upregulated, while Scd3 was downregulated in
the skin of K5cre-CMVcaNrf2 mice (Fig 3D). Similar alterations in
the expression of these genes were also detected in wild-type mice
upon activation of endogenous Nrf2 by repeated tBHQ treatment
(Supplementary Fig 6D,E). However, expression of Adph, Pparg,
and Scd1 were not significantly upregulated at P2.5 in K5cre-
CMVcaNrf2 mice (Fig 3E), suggesting that the regulation of these
genes is not a direct consequence of Nrf2 activation, but rather a
consequence of the increase in sebocyte proliferation and abnormal-
ities in sebocyte differentiation.
High-performance thin-layer chromatography of the back skin
lipids of K5cre-CMVcaNrf2 mice revealed a 27% reduction in triacyl-
glycerides, while the levels of fatty acids, cholesterol, and choles-
terol- and wax esters were normal (Fig 3F,G). These alterations in
sebocyte lipid metabolism may involve the deregulation of Scds in
K5cre-CMVcaNrf2 mice.
Nrf2 activation induces hyperproliferation of sebocytes by
upregulation of epigen
To determine the molecular mechanisms underlying the sebocyte
phenotype, we analyzed microarray data from skin of P2.5 control
and K5cre-CMVcaNrf2 mice (Scha¨fer et al, 2012). Interestingly, this
analysis revealed upregulation of the epidermal growth factor (EGF)
family member epigen (Epgn), which had previously been shown to
induce sebocyte enlargement when overexpressed in transgenic mice
(Dahlhoff et al, 2009). In situ hybridization revealed strong Epgn
expression in the interfollicular epidermis and the pilosebaceous
unit, including SGs, in control and in particular in K5cre-CMVcaNrf2
mice (Fig 3H, Supplementary Fig 6F representing different staining
intensities). Furthermore, qRT-PCR analysis confirmed upregulation
of Epgn in the back skin of P2.5 and P32 K5cre-CMVcaNrf2 mice
(Fig 3I) and in their preputial glands (Supplementary Fig 6G), as well
as in the tail skin of K5cre-caNrf2 mice (Supplementary Fig 6C). We
also found increased expression of other EGF family members,
including amphiregulin (Areg), betacellulin (Btc), epiregulin (Ereg),
and heparin-binding EGF-like growth factor (Hbegf) in the skin of
P32 (Fig 3J), but not of P2.5 K5cre-CMVcaNrf2 mice.
Inhibition of EGFR signaling by systemic treatment of control
and K5cre-CMVcaNrf2 mice with the EGFR kinase inhibitor Gefitinib
(Iressa) resulted in a 25% reduction in SG area of control mice com-
pared with vehicle-treated mice, and an even stronger reduction
(33%) in K5cre-CMVcaNrf2 mice (Fig 4A). These results suggest
that the hyperproliferation and hyperplasia of the SG are the
consequence of elevated expression of EGF family members, fol-
lowed by enhanced EGFR signaling. Epgn seems to be the initial
growth stimulus, since it was upregulated in P2.5 K5cre-CMVcaNrf2
mice and thus prior to the development of the SG phenotype. Con-
sistent with this hypothesis, transgenic mice expressing human
EPGN under control of a CMV enhancer and b-actin promoter also
showed enhanced sebocyte proliferation and severe SG hyperplasia
(Dahlhoff et al, 2009). Moreover, the regulation of Adph, Pparg
Mc5r, and Scd1, 2, 3, and 4 was similar in EPGN transgenic mice
and K5cre-CMVcaNrf2 mice (Fig 4B,C; see Fig 3C,D).
Epigen is a direct target of Nrf2, which is upregulated upon
Nrf2 activation
Upregulation of Epgn expression was observed in primary keratino-
cytes from K5cre-CMVcaNrf2 mice (Fig 4D) as well as in sulfora-
phane-treated keratinocytes from wild-type mice, but not from
Nrf2ko mice (Fig 4E). Thus, it occurs in a cell-autonomous and Nrf2-
dependent manner, suggesting that Epgn is a direct Nrf2 target gene.
This hypothesis is supported by in silico identification of a classical
antioxidant response element (ARE; Nrf2 binding site) (Rushmore
et al, 1991) in the murine Epgn gene promoter, 4.8 kb upstream of
the transcription start site (Fig 4F). Chromatin immunoprecipitation
(ChIP) using a mixture of lysates from back and tail epidermis of
wild-type mice using an Nrf2 antibody revealed binding of endoge-
nous Nrf2 to the Epgn ARE, but not to a different promoter region
(Fig 4G). ChIP analysis of lysates using a histone H3 dimethyl Lys4
(H3K4me2) antibody, a marker of transcriptionally active chromatin
(Pekowska et al, 2011), showed no increase in histone H3 dimethyla-
tion at the Epgn ARE compared with a non-coding DNA region
(ncDNA) in control mice (Fig 4H). This suggests that Epgn gene
expression is not activated by endogenous Nrf2 under homeostatic
conditions. However, there was an increase in histone H3 dimethyla-
tion at the Epgn ARE in K5cre-CMVcaNrf2 mice (Fig 4I), indicating
that caNrf2 activates Epgn transcription via binding to the identified
ARE. Taken together, these data reveal that Nrf2 binds to the Epgn
ARE and that Nrf2 activation enhances Epgn gene transcription. This
leads to increased EGFR signaling and concomitant induction of sebo-
cyte proliferation, resulting in sebaceous gland hyperplasia (Fig 4J).
Acanthosis and hyperkeratosis of infundibula in K5cre-
CMVcaNrf2 mice are most likely the consequence of Slpi, Sprr2d,
and Epgn upregulation
BrdU labeling showed that thickening of hair follicle infundibula
results from increased proliferation of keratinocytes (Fig 5A). Gefiti-
nib treatment caused a minor reduction in the thickness of infundibu-
la (Fig 5B), but a significant reduction in the proliferation rate of
keratinocytes compared with vehicle-treated mice (Fig 5C). Thus,
activation of EGFR signaling obviously enhances keratinocyte prolif-
eration and hyperplasia of infundibula in K5cre-CMVcaNrf2 mice.
In the epidermis, Nrf2-mediated upregulation of Sprr2d reduced
the mechanical stability of the corneocytes, resulting in an impair-
ment of epidermal barrier function (Scha¨fer et al, 2012). This defi-
ciency caused mild inflammation and upregulation of keratinocyte
mitogens, resulting in keratinocyte hyperproliferation. We also
found upregulation of Sprr2 expression in differentiated keratino-
cytes of infundibula (Fig 5D upper panel) and a clustering of mast
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cells around the hair follicles of K5cre-CMVcaNrf2 mice (Fig 5D
middle panel). This result strongly suggests that Sprr2d upregulation
causes acanthosis of infundibula by reducing barrier functionality
(see model in Fig 5F).
Slpi, which inhibits kallikrein 7, a protease required for corne-
odesmosome cleavage (Franzke et al, 1996), was significantly upreg-
ulated in the epidermis of K5cre-CMVcaNrf2 transgenic mice,
leading to reduced desquamation and consequently hyperkeratosis
(Scha¨fer et al, 2012). We observed a significant overexpression of
Slpi in the IFN and infundibular stratum corneum (Fig 5D lower
panel) and impaired corneodesmosome degradation in the IFN
(Fig 5E). Thus, follicular hyperkeratosis in K5cre-CMVcaNrf2 mice
most likely results from increased expression of Slpi, which inhibits
corneocyte desquamation (Fig 5F).
Interestingly, Sprr2d and Slpi were both upregulated in preputial
glands of K5cre-CMVcaNrf2 mice, which became hyperkeratotic
upon aging (Supporting Information Fig 6G), suggesting a similar
mechanism of action of activated Nrf2 in skin and preputial glands.
Cyst formation in K5cre-CMVcaNrf2 mice is the consequence of
continuous follicular hyperkeratosis
K5cre-CMVcaNrf2 mice had a milder epidermal phenotype at 6 m
compared with P32 due to partial silencing of caNrf2 expression and
A
D
G H I J
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Figure 4. Regulation of Epgn by Nrf2.
A Average SG area of P32 tg/wt and tg/tg mice injected with vehicle or Gefitinib. Note reduction in SG area upon Gefitinib treatment of tg/wt mice (N = 6/5,
**P = 0.0025) and tg/tg mice (N = 4, *P = 0.0286).
B, C qRT-PCR of Adph, Pparg Mc5r (B), and Scd1, 2, 3, 4 (C) relative to Gapdh using RNA of back skin from wt and EPGN-tg mice (N = 3).
D, E qRT-PCR of Epgn using RNAs of murine primary keratinocytes of tg/wt and tg/tg mice (N = 3) (D), or immortalized keratinocytes of wt and Nrf2ko mice treated with
vehicle or sulforaphane (E) (N = 4, *P = 0.0286).
F Localization of PCR-amplified non-specific region (ns), promoter region (prom), and antioxidant response elements (AREs) in the murine Nqo1 and Epgn genes.
G Chromatin immunoprecipitation (ChIP) using lysates from back and tail skin of control mice. Note the enhanced binding of Nrf2 to the Epgn ARE compared with the
ns region (Nqo1 ns, N = 6, Nqo1 ARE, N = 6, **P = 0.0045; Epgn ARE, N = 4, *P = 0.012).
H, I ChIP using back and tail skin lysates of tg/wt (H) and tg/tg mice (I) with an H3K4me2 antibody. Regions void of annotated ORFs (non-coding, nc DNA), Epgn prom,
and Epgn ARE were amplified by qRT-PCR. Note the increase in histone H3 dimethylation at the Epgn ARE compared with ncDNA in tg/tg mice (N = 2/3).
J Working model: Nrf2 activation leads to increased Epgn expression, which activates EGFR signaling. This enhances proliferation of sebocyte progenitors, leading to
sebaceous gland hyperplasia.
Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test.
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consequent downregulation of Nrf2 target genes (Scha¨fer et al,
2012). At the age of 1 year, they showed an even further decrease in
expression of the classical Nrf2 target genes Nqo1 (Fig 6A) and
Srxn1 (Fig 6B). Expression of Epgn had significantly declined at 6 m
(Fig 6C), providing a likely explanation for the low sebum content
in the cyst lumen (see Fig 2E) and the reduced size or even absence
of SGs associated with large cysts. The decline in Sprr2d (Fig 6D)
and Slpi (Fig 6E) expression upon aging of K5cre-CMVcaNrf2 mice,
however, was less pronounced, and in particular Slpi mRNA levels
were still more than 20-fold higher than in control animals at
the age of 1 year (Fig 6E). Consistently, immunohistochemistry
revealed strong staining for Slpi in the epithelium and keratin-filled
lumen of the cysts of aged K5cre-CMVcaNrf2 mice (Fig 6F). Thus,
continuous high expression of Slpi and a consequent reduction of
corneocyte desquamation seem to underlie the development of kera-
tinized cysts in aged mice. These findings suggest that differences in
the ratio of individual Nrf2 targets result in different cutaneous
abnormalities.
A
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Figure 5. Sprr2d and Slpi expression in infundibula of K5cre-CMVcaNrf2 mice.
A Average number of BrdU-positive cells in infundibula (INF) of tg/wt and tg/tg mice (N = 4).
B,C Average thickness of infundibula and number of PCNA-positive cells in infundibula of P32 tg/wt and tg/tg mice injected with vehicle or Gefitinib (N = 4/5).
D Upper panel: immunohistochemistry of Sprr2 on longitudinal P10 tg/wt and tg/tg back skin sections. Note staining of Sprr2 in differentiated infundibular keratinocytes
in tg/tg mice. Scale bar: 25 lm. Middle panel: toluidine blue staining for detection of mast cells on longitudinal back skin sections of P32 tg/wt and tg/tg mice. Note
increase in number of mast cells in tg/tg mice and assembly of mast cells along the interfollicular epidermis and upper part of the hair follicles. Scale bar: 100 lm.
Lower panel: immunohistochemistry of Slpi on longitudinal P10 tg/wt and tg/tg back skin sections. Inset in lower panel shows immunohistochemistry without
primary antibody. The dashed line marks the basement membrane of the interfollicular epidermis. Note staining of Slpi (indicated by arrow) in differentiated
infundibular keratinocytes and stratum corneum in tg/tg mice. Scale bar: 25 lm.
E Electron microscopy of infundibular stratum corneum of P32 tg/wt and tg/tg mice. Corneocyte layers in lower panel were numbered from basal to distal (C1–C3).
Arrows point to corneodesmosomes. Note delayed corneodesmosome degradation in tg/tg mice. C, corneocyte.
F Working model: Nrf2 activation leads to upregulation of Slpi, Sprr2d, and Epgn in hair follicle infundibula. Slpi upregulation promotes inhibition of CE protease
activity. Consequently, corneodesmosome cleavage is reduced, leading to decreased desquamation and thereby to hyperkeratosis of infundibula. Sprr2d upregulation
reduces epidermal barrier functionality, resulting in increased inflammation and consequently stimulation of proliferation. Epgn and other epidermal growth factor
(EGF) family members stimulate proliferation of infundibular keratinocytes via EGFR signaling. Together, this results in acanthosis of hair follicle infundibula.
Data information: Values are shown as the mean with s.d.
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SPRR2 and SLPI are strongly expressed in cysts of
MADISH patients
The histopathological features of K5cre-CMVcaNrf2 mice showed
remarkable similarities to the cutaneous abnormalities seen in
patients with chloracne/MADISH (Saurat & Sorg, 2010), including
hair follicle proliferation, hyperplasia, and hyperkeratosis as well as
formation of keratinized cysts with small or no SGs (Fig 7A) (Pan-
teleyev & Bickers, 2006). This prompted us to investigate the poten-
tial involvement of similar pathomechanisms in caNrf2-transgenic
mice and MADISH patients. Indeed, we detected strong expression
of SPRR2, SLPI, EPGN and of the classical NRF2 target NQO1 in the
epidermis and cyst epithelium of MADISH patients, with particularly
strong staining of SPRR2, SLPI, and NQO1 in differentiated keratino-
cytes (Fig 7B–E). Since all these genes are concomitantly activated
by caNrf2 in mouse keratinocytes in vivo, it seems most likely that
NRF2 is activated in keratinocytes of MADISH patients. The conse-
quent upregulation of SLPI, SPRR2, and EPGN could then contribute
to cyst formation in the skin of MADISH patients by the observed
interference with stratum corneum desquamation and epidermal
barrier formation.
Dioxin treatment enhances expression of SLPI, SPRR2D, and EPGN
in human keratinocytes in an Nrf2-dependent manner
The pathology of MADISH patients develops after intoxication with
halogenated aromatic hydrocarbons, such as 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (TCDD) (Geusau et al, 2001; Sorg et al, 2009;
Saurat et al, 2012). Interestingly, we found upregulation of SLPI,
SPRR2D, and EPGN in cultured human foreskin keratinocytes
(HFKs) by treatment with TCDD (Fig 8A). TCDD is known to acti-
vate the aryl hydrocarbon receptor (AHR), and this was verified by
the strong increase in the expression of cytochrome P450 1A1 and
1B1 (CYP1A1 and CYP1B1) (Fig 8B), which are major AHR target
genes (Hayes et al, 2009). Concomitantly, expression of NRF2 and
NQO1 was induced (Fig 8C). This finding is consistent with previ-
ous observations showing that TCDD via AHR leads to increased
expression and/or activation of NRF2 in different cell types (Hayes
et al, 2009). We next transfected HFKs with two different siRNAs
targeting NRF2 mRNA (Supplementary Fig 7A). Interestingly, the
basal and TCDD-induced expression of NQO1, SLPI, SPRR2D, and
EPGN was strongly diminished after transfection with NRF2 siRNA
(Fig 8D). Furthermore, transfection with two different siRNAs tar-
geting AHR (Supplementary Fig 7B) resulted in a strong reduction of
the TCDD-induced expression of SLPI, SPRR2D, and EPGN (Fig 8E).
These data provide evidence for a TCDD-induced activation of an
AHR-NRF2 axis in MADISH patients, which results in upregulation
of the NRF2 targets SLPI, SPRR2D, and EPGN with subsequent devel-
opment of cystic lesions.
Discussion
Nrf2-activating compounds are used for skin protection under stress
conditions as well as for cancer prevention. Unfortunately, there is
accumulating evidence for severe adverse effects of Nrf2 activation.
A
E F
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Figure 6. Differential regulation of Nrf2 target genes in K5cre-CMVcaNrf2 mice.
A–E qRT-PCR for Nqo1, Srxn1, Epgn, Sprr2d, and Slpi relative to Gapdh using RNAs from skin of P2.5, P32, 6-m- and 1-y-old tg/wt and tg/tg mice (N = 3/4). Expression in tg/
wt mice was arbitrarily set as 1.
F Immunohistochemistry of Slpi on 1 y tg/wt and tg/tg back skin sections. Note strong staining of Slpi in cyst epithelium and keratinized lumen compared with
differentiated keratinocytes of the epidermis (indicated by arrow). Scale bar: 100 lm.
Data information: Values are shown as the mean with s.d.
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In this study, we identified unexpected abnormalities in the pilose-
baceous unit upon long-term activation of Nrf2 in the skin. The phe-
notype was dependent on the level and duration of Nrf2 activation,
which resulted in different ratios of Nrf2 targets. This needs to be
considered when Nrf2-activating compounds are used for skin pro-
tection in vivo.
We identified acanthosis and hyperkeratosis of infundibula
and the interfollicular epidermis as the reason for dilatation of
infundibula in caNrf2-transgenic mice. These alterations prevent
sebum outflow due to narrowing and plugging of the hair canal. An
increase in sebum production by the enlarged SG further aggravates
sebum congestion. The dilatation of infundibula, in turn, reduces
A
B C
D E
Figure 7. Histopathological features and expression of SPRR2D and SLPI in MADISH patients.
A Left: transverse section of tail skin from 1-y-old K5cre-CMVcaNrf2 mouse with large cyst. Middle: section of pre-auricular skin biopsy of a MADISH patient. Right:
close-up as indicated by rectangle in middle picture. Note lack of SGs and large cutaneous keratinized cysts in skin section of K5cre-CMVcaNrf2 mouse and MADISH
patient.
B, C Immunohistochemistry staining of SPRR2 (B) and SLPI (C) on skin section of MADISH patients. Left upper picture in (B): negative control lacking primary antibody and
with secondary antibody used for SPRR2 and SLPI staining. Left upper picture in (C): SLPI staining in cyst epithelium. Right upper picture: SPRR2 (B) and SLPI staining
(C) in epidermis (arrow). Lower panel: cyst in overview (left) and close-up as indicated by rectangle. Note strong SPRR2 and SLPI staining in differentiated cyst
keratinocytes and epidermis (arrow). Scale bars: 100 lm (left), 50 lm (right).
D, E Immunohistochemistry of NQO1 and EPGN on skin section of MADISH patient. Upper left picture: negative control secondary antibody only. Upper right picture:
NQO1 (D) and EPGN staining (E) in epidermis. Lower panel: cyst in overview (left) and close-up as indicated by rectangle. Note strong NQO1 staining in differentiated
keratinocytes and strong EPGN staining in all keratinocytes of cysts and epidermis (arrow). Inset in lower left panel in (E) shows EPGN staining in endothelial cells
(positive control). Scale bars: 100 lm (left) and 50 lm (right).
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the anchorage of hairs, providing a likely explanation for their
premature loss during late catagen and telogen. By contrast, we
excluded alterations in hair follicle morphogenesis or cycling or in
the differentiation of hair follicle keratinocytes. The follicular and
epidermal hyperkeratosis and acanthosis also explain the thinning
and malformation of hairs, because they prevent a proper
outgrowth of newly forming hairs during anagen. The hair loss also
promotes the occlusion of the hair canal and thereby sebum conges-
tion and dilatation of infundibula.
Several results of this study strongly suggest that Nrf2-induced
upregulation of Epgn is the primary reason for the observed SG
abnormalities and the acanthosis of infundibula: (i) Epgn was upreg-
ulated in K5cre-CMVcaNrf2 mice prior to the development of his-
tological abnormalities, and it was strongly expressed in the
pilosebaceous unit, including the SGs of adult K5cre-CMVcaNrf2
mice; (ii) EPGN transgenic mice showed similar abnormalities of the
pilosebaceous unit and epidermis (Dahlhoff et al, 2009), including a
similar expression profile of genes involved in sebocyte differentia-
tion and lipid metabolism (this study); (iii) pharmacological block-
ade of EGFR signaling reduced hyperplasia of SGs and proliferation
of infundibula in K5cre-CMVcaNrf2 mice; (iv) Epgn upregulation
occurred in a cell-autonomous and Nrf2-dependent manner in cul-
tured keratinocytes; and (v) ChIP experiments revealed that Nrf2
binds to a distal ARE in the Epgn promoter region and that Nrf2 acti-
vation causes transcriptional activation of Epgn.
In addition to this direct effect, acanthosis of infundibula in
K5cre-CMVcaNrf2 mice may result at least in part from upregulation
of Sprr2d and subsequent disruption of the follicular barrier. This
allows the penetration of allergens and/or bacteria from the lumen
of hair follicles, which are colonized by commensal microbes (Nak-
atsuji et al, 2013). The resulting accumulation of immune cells stim-
ulates proliferation of keratinocytes in a paracrine manner through
upregulation of keratinocyte mitogens as previously demonstrated
for epidermal keratinocytes (Scha¨fer et al, 2012). The infundibular
A
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Figure 8. TCDD upregulates SLPI, SPRR2D, and EPGN in an AHR- and NRF2-dependent manner in human foreskin keratinocytes.
A–C qRT-PCR for SLPI, SPRR2D, and EPGN (A), CYP1A1 and CYP1B1 (B), NRF2, NQO1, SRXN1, and GCLC (C), relative to GAPDH using RNAs from 108 M TCDD and vehicle-
treated human foreskin keratinocytes (HFKs) (N = 3). Expression in vehicle-treated HFKs was arbitrarily set as 1.
D, E qRT-PCR of NQO1, SLPI, SPRR2D, and EPGN relative to GAPDH using RNA from HFKs transfected with siRNA targeting NRF2 (Nrf2-2 or Nrf2-7) (D) or AHR (AHR1 or
AHR2) (E) or scrambled (scr) siRNA (D,E) (N = 3/4). Cells were treated with 108 M TCDD or vehicle. Note downregulation of NQO1, SLPI, SPRR2D, and EPGN in cells
transfected with siRNAs targeting NRF2 or AHR.
Data information: Values are shown as the mean with s.d.
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hyperkeratosis and impaired stratum corneum desquamation can be
explained by overexpression of Slpi, a direct target of Nrf2 (Iizuka
et al, 2005), in the infundibula of K5cre-CMVcaNrf2 mice. The pre-
viously demonstrated inhibition of kallikrein 7 activity by Slpi
(Franzke et al, 1996) likely inhibits corneodesmosome cleavage in
the infundibular stratum corneum, resulting in impaired
desquamation and ultimately follicular hyperkeratosis. Taken
together, these results reveal previously unrecognized functions of
Slpi, Sprr2d, and Epgn in the pilosebaceous unit.
In aged K5cre-CMVcaNrf2 mice, we observed large keratin-filled
cysts, in particular in the tail. The different histopathological
abnormalities in aged versus young mice may be due to different
ratios in the expression levels of individual Nrf2 target genes. In
general, there was an age-dependent decline in the expression of
Nrf2 target genes in K5cre-CMVcaNrf2 mice. Epgn expression
showed a peak at P32, but was strongly reduced already in 6-m-old
mice. This provides a likely explanation for the marginal sebum in
the cyst lumen and the reduced size or lack of SG associated with
cysts in 1-year-old K5cre-CMVcaNrf2 mice. By contrast, the age-
dependent decline in Sprr2d and in particular in Slpi expression
was less pronounced. The continuously high expression of these
proteins is likely to be responsible for the progressive hyperkerati-
nization of infundibula and formation of keratinized cutaneous
cysts upon aging.
Follicular hyperkeratosis and acanthosis together with SG hyper-
plasia and seborrhea as seen in young K5cre-CMVcaNrf2 mice are
important characteristics of acne in humans. However, the develop-
ment of Acne Vulgaris also involves Propionibacterium (P.) acnes
overgrowth, which only affects humans, but not mice, and which
triggers a severe inflammatory response (Makrantonaki et al, 2011).
K5cre-CMVcaNrf2 transgenic mice only had mild inflammation, pre-
sumably due to an epidermal barrier defect (Scha¨fer et al, 2012),
but not as a result of P. acnes overgrowth. Therefore, the phenotype
of caNrf2 mice rather resembles the abnormalities seen in human
non-inflammatory acne, in particular Acne Comedonica.
The keratinization of the cyst lumen and reduction or lack of SGs
in aged mice, in contrast, are remarkably reminiscent to the pathol-
ogy that develops in MADISH patients (Panteleyev & Bickers, 2006;
Saurat et al, 2012). Indeed, we found strong expression of NQO1,
SLPI, SPRR2, and EPGN in the affected epidermis and cyst epithe-
lium of these patients. The nuclear staining of SPRR2 in the human
epidermis is consistent with the nuclear localization and DNA bind-
ing activity of SPRR2 that protects DNA from ROS damage (Vermeij
et al, 2012). Upregulation of Slpi, Sprr2d, and Epgn was detected by
microarray analysis using RNA of P2.5 K5cre-CMVcaNrf2 mice
(Scha¨fer et al, 2012). These genes seem to be the major drivers of
the skin phenotype, since no other genes encoding growth factors or
proteins involved in epidermal barrier function/keratinization were
regulated at this early time point. It had previously been shown that
TCDD induced the expression of various genes of the human epider-
mal differentiation complex (Sutter et al, 2011). However, we did
not detect an increase in the expression of these genes in P2.5
K5cre-CMVcaNrf2 mice by microarray analysis, and this was con-
firmed for loricrin (Scha¨fer et al, 2012), Sprr1a (Scha¨fer et al, 2012),
Sprr2a, late cornified envelope (Lce)1a, and S100A7 by qRT-PCR
(Supplementary Fig 6H), indicating that these genes do not contrib-
ute to the phenotype. Rather, the combination of SPRR2D and
the newly identified TCDD targets SLPI and EPGN is most likely
sufficient to induce the MADISH-like pathology in K5cre-CMVcaNrf2
mice and also in MADISH patients. Thus, the mechanistic studies
performed in mice together with the strong expression of SLPI,
SPRR2, and EPGN in affected skin of MADISH patients provide
strong evidence for a contribution of these proteins to the cyst
development in MADISH patients by mediating follicular hyperpla-
sia and hyperkeratosis.
Metabolizing acquired dioxin-induced skin hamartomas devel-
ops upon exposure to halogenated aromatic hydrocarbons, such as
TCDD, which activates AHR. The important role of AHR in MA-
DISH pathogenesis is supported by the finding that transgenic mice
expressing a constitutively active mutant of the Ahr receptor
(caAhr) in keratinocytes also develop epidermal cysts (Tauchi
et al, 2005). It has previously been shown that TCDD-activated
AHR induced NRF2 activation in different cell types in vitro (Hayes
et al, 2009), and Nrf2 was also activated in transgenic mice
expressing caAhr in keratinocytes (Tauchi et al, 2005). However, a
role of NRF2 in TCCD-induced cyst development in MADISH
patients has not been demonstrated so far. We found that TCCD
stimulated the expression of the classical NRF2 target NQO1 in
human foreskin keratinocytes, and TCCD-mediated upregulation of
SLPI, SPRR2D, and SLPI was NRF2 and AHR dependent. Further-
more, NQO1 was strongly expressed in the cyst epithelium of
MADISH patients. This suggests that SLPI, SPRR2D, and SLPI are
also upregulated by TCDD-mediated activation of AHR and NRF2
in vivo under these conditions. By contrast, upregulation of these
genes is not a general response of hyperproliferative keratinocytes,
since it was not observed in human basal cell carcinomas (Supple-
mentary Fig 7C).
Although TCCD induced the expression of NQO1 and the novel
NRF2 targets EPGN, SPRR2D, and SLPI in cultured human keratino-
cytes in an NRF2-dependent manner, no significant upregulation of
various other classical NRF2 target genes was detected. It may well
be that the rather weak activation of NRF2 by TCCD is insufficient
to induce the expression of most classical NRF2 target genes, with
the exception of NQO1, which is particularly sensitive to NRF2 acti-
vation. TCDD-mediated induction of SPRR2D, SLPI, and EPGN may
be achieved by a combination of NRF2 and AHR that is more potent
than NRF2-mediated activation alone. This novel NRF2-AHR cross-
talk needs further investigations at the molecular level. Independent
of the regulatory mechanisms, our data provide strong evidence for
a potent function of the newly discovered AHR-NRF2-SLPI/
SPRR2D/EPGN axis in the pathogenesis of MADISH. Since this axis
is also activated in K5cre-CMVcaNrf2 mice, these animals provide
an interesting novel model to study this important toxin-induced
disorder.
Materials and Methods
RNA isolation and qRT-PCR
Total cellular RNA was isolated as previously described (Chomczynski
& Sacchi, 1987; Werner et al, 1993) and further purified using the
Nucleospin RNAII kit (Macherey-Nagel, Du¨ren, Germany) or the
MinElute kit (Qiagen, Hilden, Germany). cDNA synthesis and qRT-
PCR were described previously (Yang et al, 2010). Primers used are
listed in Supplementary Table 2.
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Histological and immunohistological stainings and labeling
with BrdU
Histological and immunofluorescence analyses were described ear-
lier (Scha¨fer et al, 2010). For antigen retrieval, PFA-fixed paraffin
sections were heated up from room temperature to 95°C and
incubated for 1 h at 95°C (for SLPI, SPRR2D, and EPGN). Primary
antibodies used were anti-Adph (Fitzgerald, Acton, MA, USA),
anti-BrdU-POD (Roche, Rotkreuz, Switzerland), anti-PCNA, and
anti-Slpi (all from Santa Cruz, CA, USA), anti-Nrf2 (Huebner et al,
2012), anti-H3K4me2 (Active Motif, Carlsbad, CA, USA), anti-Epgn,
anti-NQO1 (Abcam, Cambridge, UK), anti-SPRR2 (kindly provided
by Dr. Daniel Hohl, Lausanne, Switzerland), and antibodies against
keratins K17, K75, K28, K82, and K33 (L. Langbein). Donkey anti-
guinea pig-Cy3, goat anti-mouse-biotin (Vector Laboratories, Burlin-
game, CA, USA), and goat anti-rabbit-biotin (Jackson
ImmunoResearch, West Grove, PA, USA) were used as secondary
antibodies.
BrdU short-term labeling and detection as well as Oil Red O stain-
ing were previously described (Scha¨fer et al, 2012).
Preparation of epidermal whole mounts
Skin was manually peeled off from the mouse tail, cut into approxi-
mately 1-cm-long pieces, and incubated in a solution containing
2.5 U/ml dispase (Invitrogen, Carlsbad, CA, USA) in PBS for 2 h at
37°C. Epidermal sheets were separated from the dermis and fixed
overnight in 4% PFA or in 95% ethanol/1% acetic acid.
Morphometrical analysis
Paraffin-embedded back skin was cut longitudinally; tail and eyelid
skin were cut transversally to obtain 7-lm sections. Morphometri-
cal analysis of the SG and meibomian gland areas was performed
on Adph or hematoxylin/eosin (H&E)-stained serial transverse sec-
tions. The gland size of meibomian glands and tail SG was com-
pared at its largest extent. Morphometrical analysis of back skin
SG was performed on longitudinal sections. Only areas, where the
hair follicles were cut longitudinally, were analyzed. For all analy-
ses, the Openlab 3.1.5 software (Perkin Elmer, Waltham, MA,
USA) was used.
Lipid analysis and quantification
Lipids were extracted from the back skin and analyzed as described
previously. The lipids of interest, which contain free fatty acids, tri-
acylglycerol, cholesterol, and cholesterol- and wax esters, were first
separated by HPTLC and subsequently quantified by densitometry.
In particular, the mentioned lipids were applied in form of thin
bands (1 cm in length) automatically on 20 × 10 cm silica HPTLC
plates (VWR, Germany). The bands were then separated using a sol-
vent mixture containing n-hexane, diethyl ether, and acetic acid
(70:30:1 by volume). After drying, the HPTLC plates were dipped
into an aqueous solution containing 10% CuSO4 and 8% H3PO4
(w/v). Heating of the plates to 160°C for 10 min led to visualization
of the separated lipids. Visualized lipid bands were quantified using
a densitometric scanner (TLC scanner 3; CAMAG, Germany) in the
reflectance mode at 595 nm. Quantitative results were obtained by
relating the intensities of the separated lipid bands to calibration
curves of corresponding standards.
Chromatin immunoprecipitation
Chromatin lysate was pre-cleared and incubated overnight with
antibodies against Nrf2 (Huebner et al, 2012), Sprr2 (see above),
histone H3 (Abcam, Cambridge, UK), histone H3K4me2, and nor-
mal sheep IgG (Upstate/Millipore, Billerica, MA, USA). To analyze
protein-bound DNA, primers for qPCR were used (Supplementary
Table 2). The percentage of the input that was bound was calcu-
lated by the delta Ct method and averaged over at least three exper-
iments.
Animal experiments
For activation of endogenous Nrf2 in the skin, wild-type mice were
topically treated twice a day for 10 consecutive days starting at P0
with 10 mM sulforaphane or 50 mM tBHQ (both from Merck,
Darmstadt, Germany) in hydrophilic cream (33%) (Ha¨nseler, Heri-
sau, Switzerland) with DMSO (66%) (vehicle).
EGFR signaling was inhibited by intraperitoneal injection of P18
K5cre-CMVcaNrf2 and control mice with 70 lg Gefitinib (Iressa)
(Santa Cruz) per gram body weight once a day for 14 consecutive
days. Gefitinib was diluted in DMSO (21%) and olive oil (79%)
(vehicle).
Mice were sacrificed by CO2 inhalation. Animal maintenance and
experiments with animals had been approved by the local veterinary
authorities of Zurich, Switzerland.
Human skin biopsies
Biopsies from affected skin of three patients with TCDD intoxication
had been taken for diagnostic purposes after informed consent and
with permission from the local ethics committee, Vienna, Austria,
and Geneva, Switzerland. Patient 1 initial TCDD level: 144,000 pg/g
blood fat, Patient 2 initial TCDD level: 26,000 pg/g blood fat, and
Patient 3 initial TCDD level: 108,000 pg/g blood fat. The skin sam-
ples had been formalin-fixed and paraffin-embedded and stored in
the files of the Department of Dermatology at the Medical University
of Vienna since 1998 and at the University of Geneva since 2005.
For the current analysis, 5-lm sections were taken and either
stained with H&E or further processed for immunohistochemical
staining as described above.
TCDD treatment and siRNA transfection of human
foreskin keratinocytes
Primary HFKs were grown in 6-cm dishes in Keratinocyte-SFM
(Gibco, Paisley, UK) supplemented with EGF and bovine pituitary
extract. They were transfected at 70% confluency with 50 nM
21-mer siRNA targeting NRF2 (Sigma-Aldrich, Buchs, Switzerland)
or AHR (Life Technologies, Carlsbad, CA, USA) using INTERFERin
(Polyplus, Illkirch, France). After 48 h at 100% confluency,
HFKs were washed with PBS and cultured for 48 h in supplement-
free Keratinocyte-SFM medium with 108M TCDD (Sigma-Aldrich)
in toluene/DMSO (0.1% final concentration) or toluene/DMSO
only.
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In situ hybridization
In situ hybridization was performed with digoxigenin-labeled sense
and antisense probes complementary to bp 91–839 of the murine
Epgn mRNA (NM_053087.2). For this purpose, the full-length cDNA
was amplified by PCR using primers that allowed the introduction
of the T7 and SP6 RNA polymerase promoter regions. 400 ng of the
purified PCR product was then used to synthesize digoxigenin-
labeled RNA probes according to the manufacturer’s instructions
(DIG RNA Labeling Kit (SP6/T7), Roche Applied Science). In situ
hybridization was performed as previously described (Brackmann
et al, 2013). Briefly, 14-lm-thick sections of back skin were post-
fixed with 4% PFA and hybridized to the Epgn antisense and sense
probes at 60°C overnight. The next day, sections were washed and
blocked, followed by incubation with an anti-digoxigenin antibody
conjugated to alkaline phosphatase (anti-digoxigenin-AP, Fab frag-
ments, Roche Applied Science) overnight. Detection of hybridized
probes was performed using NBT/BCIP solution (Roche Applied Sci-
ence).
Replicate experiments and statistical analysis
qRT-PCR analyses were performed using cDNA of three or more
mice from one litter, three or more pools of different litters, or three
or more dishes of cultured cells of one experiment. qRT-PCRs using
cDNA from cultured cells were repeated with independent samples.
Statistical analysis was performed on samples N ≥ 3 using the non-
parametric Mann–Whitney U-test for non-Gaussian distribution and
the Prism 5.0 software (GraphPad Software, La Jolla, CA, USA).
Error bars represent standard deviation.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
Acknowledgments
We thank Nicole Hallschmid, Christiane Born-Berclaz, and Nadja Bain for
excellent technical assistance, Johanna Wagner and Alain Leonid Haeller for
help with qRT-PCR experiments and immunohistochemical stainings, Dr.
Daniel Hohl, University of Lausanne, and Dr. Lars French, University of
Zurich, for helpful suggestions, Dr. Yuet Wai Kan, University of California San
Francisco, for Nrf2 knockout mice, and Dr. Daniel Hohl for the Sprr2 antibody,
and Dr. Gürkan Kaya, University of Geneva for sections from normal skin and
from MADISH patients. This work was supported by the Swiss National Science
Foundation (CRSI33_130576/1 and 310030_132884/1 to S.W), the Promedica
Foundation, Chur, Switzerland (to S.W.) and the
CE.R.I.E.S. award (to S.W.) M.S. was supported by an EMBO postdoctoral
fellowship.
Author contributions
MS performed experiments, designed the study and experiments together
with SW, and wrote the manuscript together with SW; AHW, SK, HDB,
ASL, HF, and WB performed experiments and analyzed the data; AG, FG,
OS, ET, and JHS provided samples from MADISH patients and helped with
the histological characterization; KS designed the lipid analysis experi-
ments and helped with the data analysis; MRS provided samples from
EPGN transgenic mice; AJH and DRR provided the affinity-purified Nrf2
antibody; LL provided the K28, K32, K75, K82, and K85 antibodies; SW designed
the study and the experiments together with MS and wrote the manuscript
together with MS. All authors made comments on the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Brackmann FA, Link AS, Jung S, Richter M, Zoglauer D, Walkinshaw G,
Alzheimer C, Trollmann R (2013) Activin A regulation under global hypoxia
in developing mouse brain. Brain Res 1531: 65 – 74
Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, Cone RD (1997) Exocrine
gland dysfunction in MC5-R-deficient mice: evidence for coordinated
regulation of exocrine gland function by melanocortin peptides. Cell 91:
789 – 798
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:
156 – 159
Dahlhoff M, Muller AK, Wolf E, Werner S, Schneider MR (2009) Epigen
transgenic mice develop enlarged sebaceous glands. J Invest Dermatol 130:
623 – 626
The paper explained
Problem
The Nrf2 transcription factor is a key regulator of genes involved in
the antioxidant defense system. Therefore, it is an attractive pharma-
cological target for skin protection and cancer prevention. The conse-
quences of long-term Nrf2 activation in the skin, however, remain to
be determined.
Results
Here we show that prolonged genetic and pharmacological activation
of Nrf2 in mouse keratinocytes leads to sebaceous gland enlargement
combined with hyperkeratosis and acanthosis of the hair follicle
infundibula. Together, this caused dilatation of infundibula, hair loss,
and development of large keratinized skin cysts upon aging.
Sebaceous gland enlargement resulted from increased expression of
the novel Nrf2 target epigen (Epgn), an epidermal growth factor (EGF)
family member, which caused sebocyte proliferation. Moreover, upreg-
ulation of Epgn, secretory leukocyte peptidase inhibitor (Slpi), and
small proline-rich protein 2d (Sprr2d) are responsible for the hair folli-
cle abnormalities and cyst formation upon aging.
These alterations show remarkable similarities to the cutaneous
abnormalities of patients with chloracne/“metabolizing acquired
dioxin-induced skin hamartomas” (MADISH), a severe pathology that
develops upon dioxin poisoning. The functional relevance for MADISH
pathogenesis was reflected by the strong expression of the NRF2 tar-
gets NQO1, SLPI, SPRR2D, and EPGN in affected skin of these patients
and the dioxin-mediated upregulation of these genes in human kerat-
inocytes, which occurred in an NRF2-dependent manner.
Impact
These results identified novel and unexpected activities of Nrf2 in the
control of hair follicle and sebaceous gland homeostasis, which need
to be considered when Nrf2-activating compounds are used for skin
protection and cancer prevention. Most importantly, they provide first
evidence for a role of NRF2 and downstream targets in the pathogen-
esis of MADISH.
© 2014 The Authors. EMBO Molecular Medicine Vol 6 | No 4 | 2014
M. Schäfer et al Nrf2 and acne EMBO Molecular Medicine
455
Published online: February 6, 2014 
Dinkova-Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT,
Stephenson KK, Wade KL, Talalay P (2006) Protection against
UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by
sulforaphane-containing broccoli sprout extracts. Cancer Lett 240:
243 – 252
Franzke CW, Baici A, Bartels J, Christophers E, Wiedow O (1996)
Antileukoprotease inhibits stratum corneum chymotryptic enzyme.
Evidence for a regulative function in desquamation. J Biol Chem 271:
21886 – 21890
Gao X, Dinkova-Kostova AT, Talalay P (2001) Powerful and prolonged
protection of human retinal pigment epithelial cells, keratinocytes, and
mouse leukemia cells against oxidative damage: the indirect antioxidant
effects of sulforaphane. Proc Natl Acad Sci USA 98: 15221 – 15226
Geusau A, Abraham K, Geissler K, Sator MO, Stingl G, Tschachler E (2001)
Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and
laboratory effects. Environ Health Perspect 109: 865 – 869
Gills JJ, Jeffery EH, Matusheski NV, Moon RC, Lantvit DD, Pezzuto JM (2006)
Sulforaphane prevents mouse skin tumorigenesis during the stage of
promotion. Cancer Lett 236: 72 – 79
Guillou H, Zadravec D, Martin PG, Jacobsson A (2010) The key roles of
elongases and desaturases in mammalian fatty acid metabolism: Insights
from transgenic mice. Prog Lipid Res 49: 186 – 199
Hayes JD, Dinkova-Kostova AT, McMahon M (2009) Cross-talk between
transcription factors AhR and Nrf2: lessons for cancer chemoprevention
from dioxin. Toxicol Sci 111: 199 – 201
Huebner AJ, Dai D, Morasso M, Schmidt EE, Schafer M, Werner S,
Roop DR (2012) Amniotic fluid activates the nrf2/keap1 pathway to repair
an epidermal barrier defect in utero. Dev Cell 23:
1238 – 1246
Iizuka T, Ishii Y, Itoh K, Kiwamoto T, Kimura T, Matsuno Y, Morishima Y,
Hegab AE, Homma S, Nomura A et al (2005) Nrf2-deficient mice are
highly susceptible to cigarette smoke-induced emphysema. Genes Cells 10:
1113 – 1125
Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE,
Hosoya T, Nomura A, Sakamoto T et al (2005) Transcription factor
Nrf2 plays a pivotal role in protection against elastase-induced pulmonary
inflammation and emphysema. J Immunol 175:
6968 – 6975
Kim YR, Oh JE, Kim MS, Kang MR, Park SW, Han JY, Eom HS, Yoo NJ, Lee SH
(2010) Oncogenic NRF2 mutations in squamous cell carcinomas of
oesophagus and skin. J Pathol 220: 446 – 451
van der Kraan M, Adan RA, Entwistle ML, Gispen WH, Burbach JP, Tatro JB
(1998) Expression of melanocortin-5 receptor in secretory epithelia
supports a functional role in exocrine and endocrine glands. Endocrinology
139: 2348 – 2355
Lieder F, Reisen F, Geppert T, Sollberger G, Beer HD, Auf dem Keller U, Schäfer
M, Detmar M, Schneider G, Werner S (2012) Identification of UV-protective
activators of nuclear factor erythroid derived 2-related factor 2 (Nrf2) by
combining a chemical library screen with computer-based virtual
screening. J Biol Chem 287: 33001 – 33013
Liu Y, Chan F, Sun H, Yan J, Fan D, Zhao D, An J, Zhou D (2011) Resveratrol
protects human keratinocytes HaCaT cells from UVA-induced oxidative
stress damage by downregulating Keap1 expression. Eur J Pharmacol 650:
130 – 137
Makrantonaki E, Ganceviciene R, Zouboulis C (2011) An update on the role of
the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 3:
41 – 49
Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL (2013) The
microbiome extends to subepidermal compartments of normal skin. Nat
Commun 4: 1431
Natsch A (2010) The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for
skin sensitizers–functional relevance and a hypothesis on innate reactions
to skin sensitizers. Toxicol Sci 113: 284 – 292
Panteleyev AA, Bickers DR (2006) Dioxin-induced chloracne–reconstructing
the cellular and molecular mechanisms of a classic environmental disease.
Exp Dermatol 15: 705 – 730
Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, Imbert
J, Andrau JC, Ferrier P, Spicuglia S (2011) H3K4 tri-methylation provides an
epigenetic signature of active enhancers. EMBO J 30: 4198 – 4210
Piao MS, Park JJ, Choi JY, Lee DH, Yun SJ, Lee JB, Lee SC (2012)
Nrf2-dependent and Nrf2-independent induction of phase 2 detoxifying
and antioxidant enzymes during keratinocyte differentiation. Arch
Dermatol Res 304: 387 – 395
Ramirez A, Page A, Gandarillas A, Zanet J, Pibre S, Vidal M, Tusell L, Genesca
A, Whitaker DA, Melton DW et al (2004) A keratin K5Cre transgenic line
appropriate for tissue-specific or generalized Cre-mediated recombination.
Genesis 39: 52 – 57
Rosenfield RL, Kentsis A, Deplewski D, Ciletti N (1999) Rat preputial sebocyte
differentiation involves peroxisome proliferator-activated receptors. J
Invest Dermatol 112: 226 – 232
Rushmore TH, Morton MR, Pickett CB (1991) The antioxidant responsive
element. Activation by oxidative stress and identification of the DNA
consensus sequence required for functional activity. J Biol Chem 266:
11632 – 11639
Saurat JH, Kaya G, Saxer-Sekulic N, Pardo B, Becker M, Fontao L, Mottu F,
Carraux P, Pham XC, Barde C et al (2012) The cutaneous lesions of dioxin
exposure: lessons from the poisoning of Victor Yushchenko. Toxicol Sci 125:
310 – 317
Saurat JH, Sorg O (2010) Chloracne, a misnomer and its implications.
Dermatology 221: 23 – 26
Schäfer M, Dütsch S, auf dem Keller U, Navid F, Schwarz A, Johnson DA, Johnson
JA, Werner S (2010) Nrf2 establishes a glutathione-mediated gradient of
UVB cytoprotection in the epidermis. Genes Dev 24: 1045 – 1058.
Schäfer M, Farwanah H, Willrodt AH, Huebner AJ, Sandhoff K, Roop D, Hohl
D, Bloch W, Werner S (2012) Nrf2 links epidermal barrier function with
antioxidant defense. EMBO Mol Med 4: 364 – 379
Sorg O, Zennegg M, Schmid P, Fedosyuk R, Valikhnovskyi R, Gaide O,
Kniazevych V, Saurat JH (2009) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
poisoning in Victor Yushchenko: identification and measurement of TCDD
metabolites. Lancet 374: 1179 – 1185
Sporn MB, Liby KT (2012) NRF2 and cancer: the good, the bad and the
importance of context. Nat Rev Cancer 12: 564 – 571
Sutter CH, Bodreddigari S, Campion C, Wible RS, Sutter TR (2011)
2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in
the human epidermal differentiation complex and accelerates epidermal
barrier formation. Toxicol Sci 124: 128 – 137
Tauchi M, Hida A, Negishi T, Katsuoka F, Noda S, Mimura J, Hosoya T, Yanaka
A, Aburatani H, Fujii-Kuriyama Y et al (2005) Constitutive expression of
aryl hydrocarbon receptor in keratinocytes causes inflammatory skin
lesions. Mol Cell Biol 25: 9360 – 9368
Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M (2006)
Keap1 recruits Neh2 through binding to ETGE and DLG motifs:
characterization of the two-site molecular recognition model. Mol Cell Biol
26: 2887 – 2900
456
EMBO Molecular Medicine Nrf2 and acne M. Schäfer et al
EMBO Molecular Medicine Vol 6 | No 4 | 2014 © 2014 The Authors.
Published online: February 6, 2014 
Vermeij WP, Alia A, Backendorf C (2011) ROS Quenching Potential of the
Epidermal Cornified Cell Envelope. J Invest Dermatol 131: 1435 – 1441
Vermeij WP, Florea BI, Isenia S, Alia A, Brouwer J, Backendorf C (2012)
Proteomic Identification of in Vivo Interactors Reveals Novel Function of
Skin Cornification Proteins. J Proteome Res 11: 3068 – 3076
Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S,
Imakado S, Kotsuji T, Otsuka F, Roop DR et al (2003) Keap1-null mutation
leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet
35: 238 – 245
Werner S, Weinberg W, Liao X, Peters KG, Blessing M, Yuspa SH, Weiner
RL, Williams LT (1993) Targeted expression of a dominant-negative FGF
receptor mutant in the epidermis of transgenic mice reveals a role of
FGF in keratinocyte organization and differentiation. EMBO J 12:
2635 – 2643
Yang J, Meyer M, Muller AK, Bohm F, Grose R, Dauwalder T, Verrey F, Kopf M,
Partanen J, Bloch W et al (2010) Fibroblast growth factor receptors 1 and
2 in keratinocytes control the epidermal barrier and cutaneous
homeostasis. J Cell Biol 188: 935 – 952
457© 2014 The Authors. EMBO Molecular Medicine Vol 6 | No 4 | 2014
M. Schäfer et al Nrf2 and acne EMBO Molecular Medicine
Published online: February 6, 2014 
Published online: February 6, 2014 
